Geoffrey Lynn

Geoffrey Lynn

Company: Barinthus Biotherapeutics

Job title: Senior Vice President Synthetic Immunotherapies


Intramuscularly Administered SNAP-TI Nanoparticles Induce Systemic Antigen-Specific Tolerance 3:00 pm

SNAP-TI leverages self-assembly to codeliver multiple antigens and an immunomodulator in nanoparticles optimized for targeting all major APC populations in draining lymph nodes, spleen and liver following intramuscular injection Enhanced APC uptake together with codelivered immunomodulator promote increased Treg/Teff ratio associated with efficacy in animal models of vitiligo, T1D and EAE SNAP-TI candidate for celiac…Read more

day: Day One PM Non-Cell Based Approaches

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.